Focus Recommendations - Investment Year 2022-23

Recommendations

All the Disclosures & Disclaimers apply to these recommendations.

SR. NO.	COMPANY NAME	NSE SYMBOL	BSE CODE	MARKET CAP CLASS	RECOMMENDED BUY DATE	CLOSE PRICE ON BUY DATE	RECOMMENDED SELL DATE	CLOSE PRICE ON SELL DATE	BUY DATE DISCLAIMER	SELL DATE DISCLAIMER
1	ITC Ltd	ITC	500875	LARGE/MID	31-May-2022	270.65	31-May-2023	445.5		Ownership (Self/ Family) : YES
2	UPL Ltd	UPL	512070	LARGE/MID	31-May-2022	779.60	31-May-2023	685.1		Ownership (Self/ Family) : YES
3	SRF Ltd	SRF	503806	LARGE/MID	31-May-2022	2,464.05	31-May-2023	2519.75	Ownership (Self/ Family) : YES	Ownership (Self/ Family) : YES
4	Solar Industries India Ltd	SOLARINDS	532725	LARGE/MID	31-May-2022	2,620.10	31-May-2023	3752.4		Ownership (Self/ Family) : YES
5	Timken India Ltd	TIMKEN	522113	LARGE/MID	31-May-2022	2,280.15	31-May-2023	3304.95		Ownership (Self/ Family) : YES
6	Cipla Ltd	CIPLA	500087	LARGE/MID	31-May-2022	992.95	31-May-2023	953.05		Ownership (Self/ Family) : YES
7	Sun Pharmaceutical Industries Ltd	SUNPHARMA	524715	LARGE/MID	3-Jun-2022	865.10	31-May-2023	975.35		Ownership (Self/ Family) : YES

Disclosure	ITC Ltd	UPL Ltd	SRF Limited	Solar Industries India Ltd	Timken India Limited	Cipla Ltd	Sun Pharmaceutical Industries Limited
Whether the research analyst or research entity or his associate or his relative has any financial interest in the subject company and the nature of such financial interest;	NO	NO	YES	NO	NO	NO	NO
Whether the research analyst or research entity or its associates or relatives, have actual/beneficial ownership of one per cent. or more ecurities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;	NO	NO	NO	NO	NO	NO	NO
Whether the research analyst or research entity or his associate or his relative, has any other material conflict of interest at the time of publication of the research report or at the time of public appearance;	NO	NO	NO	NO	NO	NO	NO
Whether it or its associates have received any compensation from the subject company in the past twelve months;	NO	NO	NO	NO	NO	NO	NO
Whether it or its associates have managed or co-managed public offering of securities for the subject company in the past twelve months;	NO	NO	NO	NO	NO	NO	NO
Whether it or its associates have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;	NO	NO	NO	NO	NO	NO	NO
Whether it or its associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;	NO	NO	NO	NO	NO	NO	NO
Whether it or its associates have received any compensation or other benefits from the subject company or third party in connection with the research report.	NO	NO	NO	NO	NO	NO	NO
Whether it or its associates have received any compensation from the subject company in the past twelve months;	NO	NO	NO	NO	NO	NO	NO
Whether the subject company is or was a client during twelve months preceding the date of distribution of the research report and the types of services provided:	NO	NO	NO	NO	NO	NO	NO
Whether the research analyst has served as an officer, director or employee of the subject company;	NO	NO	NO	NO	NO	NO	NO
Whether the research analyst or research entity has been engaged in market making activity for the subject company;	NO	NO	NO	NO	NO	NO	NO

Disclosure

ITC Ltd

UPL Ltd

SRF Limited

Solar Industries India Ltd

Timken India Limited

Cipla Ltd

Sun Pharmaceutical Industries Limited

Whether the research analyst or research entity or his associate or his relative has any financial interest in the subject company and the nature of such financial interest;

YES

Whether the research analyst or research entity or its associates or relatives, have actual/beneficial ownership of one per cent. or more ecurities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;

Whether the research analyst or research entity or his associate or his relative, has any other material conflict of interest at the time of publication of the research report or at the time of public appearance;

Whether it or its associates have received any compensation from the subject company in the past twelve months;

Whether it or its associates have managed or co-managed public offering of securities for the subject company in the past twelve months;

Whether it or its associates have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

Whether it or its associates have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;

Whether it or its associates have received any compensation or other benefits from the subject company or third party in connection with the research report.